Drug establishmentActive, Registered FY2026FDA warning letter on file

Avaria Health & Beauty Corp

Avaria Health & Beauty Corp is an FDA-registered drug establishment (FEI 3014583374) located in . The facility is active, registered for FY2026. Its most recent FDA inspection on record (2024-04-30) was classified OAI. FDA has issued 1 warning letter(s) to this facility.

FDA warning letter

Sep 3, 2024
CGMP/Finished Pharmaceuticals/Adulterated

A warning letter is FDA's formal notice of significant violations that require prompt correction. It can hold up product approvals, trigger import alerts, and put supply agreements at risk until the issues are resolved and FDA closes it out.

Establishment record

FEI Number
3014583374
Address
650 Jamieson Pky Unit 5, ,
Establishment type
Drug establishment
Products / operations
Manufacturing
Registration status
Active, Registered FY2026

Verify this record in FDA source data ›

Inspection history

Inspections on file
Apr 30, 2024 · Official Action Indicated (OAI)
Form 483 observations
Apr 30, 2024, 8 observations: Approve or reject components, products; Calibration/Inspection/Checking not done; Representative Samples Criteria

FDA record timeline

Warning letter
CGMP/Finished Pharmaceuticals/Adulterated
Source ›
FDA inspection
OAI classification
Form 483
8 observations

Combined chronology of the public records shown on this page. FDA coverage varies by dataset and year.

Questions

Is Avaria Health & Beauty Corp registered with the FDA?

Yes. Avaria Health & Beauty Corp is an FDA-registered drug establishment (FEI 3014583374) in . Its current registration status is Active, Registered FY2026.

Has Avaria Health & Beauty Corp received an FDA warning letter?

Yes. FDA issued a warning letter to Avaria Health & Beauty Corp; the most recent is dated Sep 3, 2024 (CGMP/Finished Pharmaceuticals/Adulterated).

What does Avaria Health & Beauty Corp do?

Avaria Health & Beauty Corp's FDA-registered operations are: Manufacturing.

Related facilities

Source: FDA public data · status as of 2026-08-22

The Quality Brief

Every new FDA drug and device warning letter and recall, summarized once a week. Free.